📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An imperfect world: assessing safety of biological treatments in systemic lupus erythematosus. Comment on the article by Materne et al (2023)

First Author: Rodziewicz M

Attributed to: MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/art.42689

PubMed Identifier: 37653671

Publication URI: http://europepmc.org/abstract/MED/37653671

Type: Journal Article/Review

Parent Publication: Arthritis & Rheumatology

Issue: 2

ISSN: 2326-5191